ALKERMES | Ordinære Aksjekapital

Ordinary Share Capital Endring Dato
AbbVie USD 18M 0 2023-09
Acadia Pharmaceuticals USD 16K 0 2023-12
ALKERMES USD 1.72M 2K 2023-09
Amgen USD 32.75B 152M 2023-09
Bristol-Myers Squibb USD 292M 0 2023-09
Eli Lilly USD 593.6M 0 2023-09
Gilead Sciences USD 1000K 0 2023-09
Intra Cellular Therapies USD 10K 0 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Merck USD 1.79B 0 2023-09
Neurocrine Biosciences USD 100K 0 2023-09
Otsuka Holdings JPY 81.69B 0 2023-09
Pfizer USD 478M 0 2023-09
Regeneron Pharmaceuticals USD 102K 0 2023-09
Vertex Pharmaceuticals USD 2.6M 0 2023-09



ALKERMES Ordinære Aksjekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.